466 related articles for article (PubMed ID: 36430910)
1. TGF-β Signaling in Metastatic Colorectal Cancer (mCRC): From Underlying Mechanism to Potential Applications in Clinical Development.
Li X; Wu Y; Tian T
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430910
[TBL] [Abstract][Full Text] [Related]
2. Pien Tze Huang inhibits liver metastasis by targeting TGF-β signaling in an orthotopic model of colorectal cancer.
Lin W; Zhuang Q; Zheng L; Cao Z; Shen A; Li Q; Fu C; Feng J; Peng J
Oncol Rep; 2015 Apr; 33(4):1922-8. PubMed ID: 25653118
[TBL] [Abstract][Full Text] [Related]
3. The Role of the Transforming Growth Factor-β Signaling Pathway in Gastrointestinal Cancers.
Matsuoka T; Yashiro M
Biomolecules; 2023 Oct; 13(10):. PubMed ID: 37892233
[TBL] [Abstract][Full Text] [Related]
4. Co-inhibition of TGF-β and PD-L1 pathways in a metastatic colorectal cancer mouse model triggers interferon responses, innate cells and T cells, alongside metabolic changes and tumor resistance.
Nair R; Lannagan TRM; Jackstadt R; Andrusaite A; Cole J; Boyne C; Nibbs RJB; Sansom OJ; Milling S
Oncoimmunology; 2024; 13(1):2330194. PubMed ID: 38516270
[TBL] [Abstract][Full Text] [Related]
5. A Novel TGF-β-Related Signature for Predicting Prognosis, Tumor Microenvironment, and Therapeutic Response in Colorectal Cancer.
Tao B; Yi C; Ma Y; Li Y; Zhang B; Geng Y; Chen Z; Ma X; Chen J
Biochem Genet; 2023 Dec; ():. PubMed ID: 38062276
[TBL] [Abstract][Full Text] [Related]
6. Role of TGF-β in metastatic colon cancer: it is finally time for targeted therapy.
Villalba M; Evans SR; Vidal-Vanaclocha F; Calvo A
Cell Tissue Res; 2017 Oct; 370(1):29-39. PubMed ID: 28560691
[TBL] [Abstract][Full Text] [Related]
7. Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment.
Itatani Y; Kawada K; Sakai Y
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31756952
[TBL] [Abstract][Full Text] [Related]
8. Bintrafusp alfa, an anti-PD-L1:TGF-β trap fusion protein, in patients with ctDNA-positive, liver-limited metastatic colorectal cancer.
Morris VK; Overman MJ; Lam M; Parseghian CM; Johnson B; Dasari A; Raghav K; Kee BK; Huey R; Wolff RA; Shen JP; Li J; Zorrilla I; Tzeng CD; Tran Cao HS; Chun YS; Newhook TE; Vauthey N; Duose D; Luthra R; Haymaker C; Kopetz S
Cancer Res Commun; 2022 Sep; 2(9):979-986. PubMed ID: 36382087
[TBL] [Abstract][Full Text] [Related]
9. S100A8 promotes epithelial-mesenchymal transition and metastasis under TGF-β/USF2 axis in colorectal cancer.
Li S; Zhang J; Qian S; Wu X; Sun L; Ling T; Jin Y; Li W; Sun L; Lai M; Xu F
Cancer Commun (Lond); 2021 Feb; 41(2):154-170. PubMed ID: 33389821
[TBL] [Abstract][Full Text] [Related]
10. Metastatic colorectal cancer: mechanisms and emerging therapeutics.
Shin AE; Giancotti FG; Rustgi AK
Trends Pharmacol Sci; 2023 Apr; 44(4):222-236. PubMed ID: 36828759
[TBL] [Abstract][Full Text] [Related]
11. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
[TBL] [Abstract][Full Text] [Related]
12. Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer.
Fan LC; Teng HW; Shiau CW; Tai WT; Hung MH; Yang SH; Jiang JK; Chen KF
Oncotarget; 2016 Sep; 7(39):64136-64147. PubMed ID: 27580057
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-β signaling: Tumorigenesis and targeting for cancer therapy.
Ahmadi A; Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Aug; 234(8):12173-12187. PubMed ID: 30537043
[TBL] [Abstract][Full Text] [Related]
14. TGF-β-Induced FLRT3 Attenuation Is Essential for Cancer-Associated Fibroblast-Mediated Epithelial-Mesenchymal Transition in Colorectal Cancer.
Yang M; Li D; Jiang Z; Li C; Ji S; Sun J; Chang Y; Ruan S; Wang Z; Liang R; Dai X; Li B; Zhao H
Mol Cancer Res; 2022 Aug; 20(8):1247-1259. PubMed ID: 35560224
[TBL] [Abstract][Full Text] [Related]
15. Effects of Chemotherapy for Metastatic Colorectal Cancer on the TGF-β Signaling and Related miRNAs hsa-miR-17-5p, hsa-miR-21-5p and hsa-miR-93-5p.
Despotovic J; Dragicevic S; Nikolic A
Cell Biochem Biophys; 2021 Dec; 79(4):757-767. PubMed ID: 33826035
[TBL] [Abstract][Full Text] [Related]
16. The clinical and biological roles of transforming growth factor beta in colon cancer stem cells: A systematic review.
Chruścik A; Gopalan V; Lam AK
Eur J Cell Biol; 2018 Jan; 97(1):15-22. PubMed ID: 29128131
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of NDRG1 promote epithelial-mesenchymal transition of colorectal cancer via NF-κB signaling.
Ma J; Gao Q; Zeng S; Shen H
J Surg Oncol; 2016 Sep; 114(4):520-7. PubMed ID: 27338835
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer: Review of signaling pathways and associated therapeutic strategies.
Leiphrakpam PD; Rajappa SJ; Krishnan M; Batra R; Murthy SS; Are C
J Surg Oncol; 2023 Jun; 127(8):1277-1295. PubMed ID: 37222698
[TBL] [Abstract][Full Text] [Related]
20. TGF-β Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma.
Alvarez MA; Freitas JP; Mazher Hussain S; Glazer ES
J Gastrointest Cancer; 2019 Jun; 50(2):207-213. PubMed ID: 30891677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
